Investing.com -- Spanish pharmaceutical company Laboratorios Farmaceuticos Rovi on Thursday reported first-half 2025 results in line with sales consensus and 4% above consensus at the EBITDA level.

For the third quarter, Robert Half expects overall revenue to decline by about 8% year-over-year to $1.36 billion at the midpoint of guidance. The company anticipates its Protiviti consulting division ...

Investing.com -- STMicroelectronics (EPA: STMPA) on Thursday reported a net loss of $97 million for the second quarter of ...

Gold and broader precious metal prices were pressured by improving risk appetite, a trend kicked off largely by the U.S. and ...

Growing use of artificial intelligence in advertising is expected to boost the global entertainment and media industry’s ...

Pressure on Seoul to reach a deal on import tariffs has increased after Japan struck a trade agreement with the U.S. this ...

News that the U.S. had struck a deal with Japan to lower new tariffs on auto imports and spare it punishing levies on other goods lifted stock markets on Wednesday. It stirred hope for a similar deal ...

Investing.com -- BE Semiconductor Industries N.V. (AS: BESI) on Thursday reported a 30.9% year-over-year decline in ...

Speaking at an event in Sydney, the Reserve Bank of Australia (RBA) governor noted that while the June monthly data showed a ...

The U.S. Treasury Department has the authority to sanction those who sell HMX and similar substances to Russia, according to ...

The Greater China Equities Hedge Fund Index tracked by With Intelligence delivered a 15% gain in the first half, topping the ...

Euro US Dollar, US Dollar Japanese Yen, US Dollar Index Futures, US Dollar Index. Read 's Market Analysis on Investing.com ...